Patents by Inventor Martin ELMLINGER

Martin ELMLINGER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • GENE EXPRESSION BIOMARKERS AND THEIR USE FOR DIAGNOSTIC AND PROGNOSTIC APPLICATION IN PATIENTS POTENTIALLY IN NEED OF HDAC INHIBITOR TREATMENT
    Publication number: 20160215348
    Abstract: The present invention relates to the utilization of one or more genes selected from the group comprising ZFP64, DPP3, CCDC43, HIST2H4A/B, KDELC2 and MICALL1 as biomarkers for HDAC inhibitor treatment. The expression and/or change of the aforementioned genes are preferably determined via the respective corresponding mRNA or one or more proteins expressed by the aforementioned genes.
    Type: Application
    Filed: May 22, 2014
    Publication date: July 28, 2016
    Applicant: 4SC AG
    Inventors: Hella KOHLHOF, Thomas HERZ, Robert DOBLHOFER, Thomas BECKERS (Deceased), Astrid ZIMMERMANN, Marina MOLLENHAUER-THEIN, Markus BOEHM, Volker GEKELER, Hans-Peter HOFMANN, Thomas MAIER, Eike STAUB, Timo WITTENBERGER, Martin ELMLINGER